Select Medical Holdings Corporation (SEM)
| Market Cap | 2.04B |
| Revenue (ttm) | 5.45B |
| Net Income (ttm) | 142.87M |
| Shares Out | 124.02M |
| EPS (ttm) | 1.16 |
| PE Ratio | 14.12 |
| Forward PE | 13.08 |
| Dividend | $0.25 (1.52%) |
| Ex-Dividend Date | Mar 2, 2026 |
| Volume | 1,504,306 |
| Open | 16.47 |
| Previous Close | 16.45 |
| Day's Range | 16.45 - 16.52 |
| 52-Week Range | 11.65 - 18.61 |
| Beta | 0.88 |
| Analysts | Buy |
| Price Target | 15.17 (-7.78%) |
| Earnings Date | Apr 30, 2026 |
About SEM
Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States. The Critical Illness Recovery Hospital segment consists of hospitals that provide services for heart failure, infectious disease, respiratory failure and pulmonary disease, surgery requiring prolonged recovery, renal disease, neurological events, and trauma. The Rehabilitation Hospital segment offers therapy and rehabilitation treatments, including reha... [Read more]
Financial Performance
In 2025, Select Medical Holdings's revenue was $5.45 billion, an increase of 5.12% compared to the previous year's $5.19 billion. Earnings were $142.87 million, a decrease of -32.52%.
Financial StatementsAnalyst Forecast
According to 4 analysts, the average rating for SEM stock is "Buy." The 12-month stock price target is $15.17, which is a decrease of -7.78% from the latest price.
News
Select Medical Holdings Corporation Announces Expiration of Hart-Scott-Rodino Waiting Period
MECHANICSBURG, Pa., April 28, 2026 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) announced today that the waiting period under the Hart-Scott...
Kaskela Law Seeks Additional Compensation for Select Medical Holdings Shareholders and Encourages Investors to Contact the Firm to Learn How to Participate
Is the buyout price of $16.50 too low? PHILADELPHIA, April 16, 2026 /PRNewswire/ -- Kaskela Law LLC is investigating the fairness of the recently announced proposed buyout of Select Medical Holdings C...
Select Medical Holdings Corporation to Announce First Quarter 2026 Results on Thursday, April 30, 2026
MECHANICSBURG, Pa., April 9, 2026 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM), will release the financial results for its first quarter ended March 31, 2026 on T...
SEM Shareholder Buyout Investigation Launched by Kaskela Law: Does $16.50 Per Share Buyout Proposal Shortchange Select Medical Shareholders?
Kaskela Law is investigating the fairness of the $16.50 per share Select Medical Holdings Corp. (“Select Medical”) (NYSE: SEM) shareholder buyout.
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Select Medical Holdings Corporation (NYSE - SEM)
BALA CYNWYD, Pa., March 03, 2026 (GLOBE NEWSWIRE) -- Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Select Medical Holdings Corpora...
Select Medical Holdings Corporation to be Acquired by Consortium Led by Robert A. Ortenzio, Martin F.
MECHANICSBURG, Pa., March 2, 2026 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) today announced that it has entered into a definitive agreeme...
Select Medical Holdings Earnings Call Transcript: Q4 2025
Q4 revenue grew over 6% year-over-year, but Adjusted EBITDA declined 10% due to higher health insurance costs. Inpatient rehab led growth, while outpatient margins fell on payer mix and discounts. 2026 guidance projects revenue of $5.6B–$5.8B and margin improvement in outpatient.
Select Medical Holdings Corporation Announces Results For Its Fourth Quarter and Year Ended December 31, 2025, Its 2026 Business Outlook, and Cash Dividend
MECHANICSBURG, Pa., Feb. 19, 2026 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) today announced results for its fourth quarter and year ended...
PHILADELPHIA EAGLES RENEW DEAL WITH SELECT MEDICAL NAMING NOVACARE REHABILITATION THE TEAM'S OFFICIAL PHYSICAL THERAPY PARTNER
MECHANICSBURG, Pa., Feb. 17, 2026 /PRNewswire/ -- Select Medical Corporation ("Select Medical") and the Philadelphia Eagles have announced a multi-year extension of its longstanding 25-year partnershi...
Select Medical Holdings Corporation to Announce Fourth Quarter and Full Year 2025 Results and Business Outlook on Thursday, February 19, 2026
MECHANICSBURG, Pa., Feb. 17, 2026 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM), will release the financial results for its fourth quarter and full year ended Dece...
Select Medical Holdings Corporation to Announce Fourth Quarter and Full Year 2025 Results on Thursday, February 19, 2026
MECHANICSBURG, Pa., Jan. 21, 2026 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM), will release the financial results for its fourth quarter and full year ended Dece...
Select Medical Holdings Corporation Acknowledges Executive Chairman's Take-Private Proposal
MECHANICSBURG, Pa. , Nov. 24, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) has received a non-binding indication of interest from Rober...
Select Medical Holdings Earnings Call Transcript: Q3 2025
Revenue and adjusted EBITDA grew over 7% year-over-year, driven by strong inpatient and critical illness recovery segments, while outpatient rehab faced margin pressure from Medicare cuts and payer mix. CMS's delay of the 20% transmittal rule provided a $12–$15 million EBITDA benefit.
Select Medical Holdings Corporation Announces Results For Its Third Quarter Ended September 30, 2025 and Cash Dividend
MECHANICSBURG, Pa. , Oct. 30, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) today announced results for its third quarter ended Septembe...
Select Medical Holdings Corporation to Announce Third Quarter 2025 Results on Thursday, October 30, 2025
MECHANICSBURG, Pa. , Oct. 2, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM), will release the financial results for its third quarter ended September 30, 2025 ...
SELECT MEDICAL HOLDINGS CORPORATION APPOINTS THOMAS P. MULLIN AS CHIEF EXECUTIVE OFFICER AND ANNOUNCES OTHER CHANGES INVOLVING LONG-TENURED LEADERS
MECHANICSBURG, Pa. , Sept. 2, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM) today announced the appointment of Thomas P.
Select Medical Holdings Earnings Call Transcript: Q2 2025
Revenue grew nearly 5% to $1.3B, with adjusted EBITDA up and EPS rising 88% year-over-year. Inpatient rehab outperformed, while critical illness recovery faced regulatory headwinds. Guidance for 2025 is reaffirmed, with strong growth and capital allocation plans.
Select Medical Holdings Corporation Announces Results For Its Second Quarter Ended June 30, 2025 and Cash Dividend
MECHANICSBURG, Pa. , July 31, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) today announced results for its second quarter ended June 30...
Select Medical Holdings Corporation to Announce Second Quarter 2025 Results on Thursday, July 31, 2025
MECHANICSBURG, Pa. , June 27, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM), will release the financial results for its second quarter ended June 30, 2025 on ...
SELECT MEDICAL SIGNS AGREEMENT WITH BALLAD HEALTH TO OPERATE JOINT VENTURE CRITICAL ILLNESS RECOVERY HOSPITAL
MECHANICSBURG, Pa. , June 27, 2025 /PRNewswire/ -- Select Medical Corporation today announced it signed a membership interest purchase agreement with Ballad Health to jointly operate Select Specialty ...
The Best Health Care Stocks to Buy
The best health care stocks offer investors a defensive hedge in an uncertain market. Here's how to find them.
Select Medical Holdings Earnings Call Transcript: Q1 2025
Inpatient rehab delivered strong growth, offsetting challenges in outpatient and critical illness recovery due to regulatory and weather impacts. Revenue rose 2% year-over-year, but adjusted EBITDA fell 9%. 2025 guidance was slightly adjusted, with robust development plans and ongoing advocacy on regulatory issues.
Select Medical Holdings Corporation Announces Results For Its First Quarter Ended March 31, 2025 and Cash Dividend
MECHANICSBURG, Pa. , May 1, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) today announced results for its first quarter ended March 31, ...
Select Medical Holdings Corporation to Announce First Quarter 2025 Results on Thursday, May 1, 2025
MECHANICSBURG, Pa. , April 8, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM), will release the financial results for its first quarter ended March 31, 2025 on ...
Select Medical Holdings Earnings Call Transcript: Q4 2024
Q4 and full-year results showed strong revenue and adjusted EBITDA growth, driven by expansion and operational improvements across all divisions. Guidance for 2025 anticipates continued revenue and EBITDA growth, with inpatient rehab margins temporarily constrained by startup costs but expected to rebound in 2026.